COYA: Coya Therapeutics, Inc. Common Stock Company Profile & Statistics

About

Coya Therapeutics Inc. is a clinical-stage biotechnology company. It involved in developing proprietary treatments focused on the biology and potential therapeutic advantages of regulatory T cells to target systemic inflammation and neuroinflammation. The company's therapeutic platforms include Treg-enhancing biologics, Treg-derived exosomes, and autologous Treg cell therapy. Coya Therapeutics Inc. is based in HOUSTON.

Info & Links

CEO

Howard Berman

Headquarters

5850 San Felipe St, Suite 500
HOUSTON, TX 77057, UNITED STATES

Auditor

Weaver and Tidwell, L.L.P.

Share holders

Employees

Coya Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

110.35M

Enterprise Value

79.30M

Enterprise Value/EBITDA(ttm)

-4.58

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

Price to Book(mrq)

2.93

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

50.00%

Operating Margin(ttm)

Profit Margin(ttm)

-1016.85%

Return on Equity(ttm)

-31.63%

Return on Invested Capital(ttm)

-32.81%

Return on Assets(ttm)

-27.76%

Income Statement

Revenue(ttm)

3.55M

Revenue Per Share(ttm)

0.21

Gross Profit(ttm)

3.55M

EBITDA(ttm)³

-17.33M

Net Income Available to Common(ttm)

-10.70M

Diluted EPS(ttm)

-0.65

Share Statistics

Beta (5Y Monthly)

0.47

52-Week Change

-28.65%

S&P 500 52-Week Change

7.67%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

16.71M

Dividend Yield

0.00%

Float⁴

14.70M

% Held by Insiders

12.00%

% Held by Institutions

39.75%

Balance Sheet

Total Cash(mrq)

31.06M

Total Cash Per Share(mrq)

1.86

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

15.31%

Quick Ratio(mrq)

15.31%

Book Value Per Share(mrq)

2.10

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.52

Free Cash Flow(ytd)

-7.90M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

COYA

Coya Therapeutics, Inc. Common Stock

Coya Therapeutics, Inc. Common Stock Profile